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S68Objective: Perfusion strategies and operative techniques for minimally invasive mitral valve repair have
evolved over time. During the past decade, our institution’s approach has progressed from a port access platform
with femoral perfusion to predominantly a central aortic cannulation through a right anterior minithoracotomy
incision. We analyzed this institutional experience to evaluate the impact of approach on patient outcomes.
Methods: Between 1995 and 2007, 1282 patients (mean age, 59.3 years; range, 18-99 years) underwent first-
time, isolated mitral valve repair using a minimally invasive technique. Patient demographics included periph-
eral vascular disease (3.2%), chronic obstructive pulmonary disease (8.3%), atherosclerotic aorta (6.5%),
cerebrovascular disease (4.3%), and ejection fraction less than 30% (4.3%). Retrograde perfusion was per-
formed in 394 (30.7%) of all patients and endoaortic balloon occlusion in 373 (29.1%); the operative technique
was a right anterior minithoracotomy in 1264 (98.6%) and left posterior minithoracotomy in 18 (1.4%). The
etiology of mitral disease was degenerative in 73.2%, functional in 20.6%, and rheumatic in 2.4%. Data
were collected prospectively using the New York State Cardiac Surgery Report System and a customized min-
imally invasive surgery data form. Logistic analysis was used to evaluate risk factors and outcomes; operative
experience was divided into tertiles.
Results: Overall hospital mortality was 2.0% (25/1282). Mortality was 1.1% (10/939) for patients with degen-
erative etiology and 0.4% (3/693) for patients younger than 70 years of agewith degenerative valve disease. Risk
factors for death were advanced age (P ¼ .007), functional etiology (P ¼ .010; odds ratio [OR] ¼ 3.3), chronic
obstructive pulmonary disease (P ¼ .013; OR ¼ 3.4), peripheral vascular disease (P ¼ .014; OR ¼ 4.2), and
atherosclerotic aorta (P ¼ .03; OR ¼ 2.8). Logistic risk factors for neurologic events were advanced age (P
¼ .02), retrograde perfusion (P¼ .001; OR¼ 3.8), and emergency procedure (P¼ .01; OR¼ 66.6). Interaction
modeling revealed that the only significant risk factor for neurologic event was the use of retrograde perfusion in
high-risk patients with aortic disease (P ¼ .04; OR ¼ 8.5). Analysis of successive tertiles during this 12-year
experience revealed a significant decrease in the use of retrograde arterial perfusion (89.6%, 10.4%, and
0.0%; P<.001) and endoaortic balloon occlusion (89.3%, 10.7%, and 0%; P<.001). The overall frequency
of postoperative neurologic events was 2.3% (30/1282) and decreased from 4.7% in the first tertile to 1.2% in
the second and third tertiles (P<.001).
Conclusions: Central aortic cannulation through a right anterior minithoracotomy for mitral valve repair allows
excellent outcomes in patients with a broad spectrum of comorbidities and has become our preferred approach
for most patients undergoing mitral valve repair. Retrograde arterial perfusion is associated with an increased
risk of stroke in patients with severe peripheral vascular disease and should be reserved for select patients with-
out significant atherosclerosis. (J Thorac Cardiovasc Surg 2012;143:S68-70)Perfusion strategies and operative techniques for mini-
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The Journal of Thoracic and Cardiovascular Surgtime; concomitantly, strategies for arterial perfusion have
changed in accordance with the reduced incision size. Dur-
ing the past decade, our institution’s approach has pro-
gressed from initially a port access platform with
femoral perfusion to central aortic cannulation through
a right anterior minithoracotomy incision. This report ana-
lyzes our perfusion and incision approaches for first-time,
isolated minimally invasive mitral valve repairs and their
outcomes.
PATIENTS AND METHODS
Clinical Characteristics
This retrospective study was approved by the New York University
School of Medicine Institutional Review Board with a specific waiver of
individual patient consent. From 1995 through 2007, 1282 patientsery c April 2012
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CI ¼ confidence interval
OR ¼ odds ratiounderwent first-time, isolated mitral valve repair using a minimally inva-
sive technique. The etiology of mitral disease was degenerative in
73.2%, functional in 20.6%, and rheumatic in 2.4%. Patients had
a mean age of 59.3 years (range, 18-99 years.). Patient demographics in-
cluded peripheral vascular disease (3.2%), chronic obstructive pulmonary
disease (8.3%), atherosclerotic aorta (6.5%), cerebrovascular disease
(4.3%), and ejection fraction less than 30% (4.3%).
Surgical Techniques
Operative technique consisted of a right anterior minithoracotomy1 in
1264 (98.6%) patients and a left posterior minithoracotomy2 in 18
(1.4%). Retrograde perfusion was performed in 394 (30.7%) of all patients
and endoaortic balloon occlusion was performed in 373 (29.1%). Initially,
a port access perfusion approach3 was used in patients without evidence of
atheromatous disease of the thoracic aorta or obstructive peripheral arterial
disease. Subsequently, perfusion strategy shifted toward central aortic can-
nulation through the right minithoracotomy incision. Surgical techniques
were standardized during this study period; only carbon dioxide insuffla-
tion was added midway during this experience.
Data Analysis
Data were prospectively collected using the New York State Cardiac
Surgery Report System and a customized minimally invasive surgery
data collection instrument. Mortality was death before hospital discharge
or within 30 days of operation. Strokewas defined as a new, permanent def-
icit, a transient deficit lasting greater than 24 hours, or a new lesion on ce-
rebral imaging. Operative experience was divided into chronologic tertiles
based on date of operation. Statistical analysis was performed using IBM
SPSS Statistics 19 software (IBM, Somers, NY), and logistic analysis
was used to evaluate risk factors and outcomes. We had full access to the
data and take full responsibility for its integrity.
RESULTS
Overall hospital mortality for minimally invasive mitral
valve repair was 2.0% (25/1282). Mortality for patients
with degenerative etiology was 1.1% (10/939) and for pa-
tients younger than 70 years of age with degenerative valve
disease mortality, 0.4% (3/693). Multivariable analysis re-
vealed that risk factors for hospital death were advanced age
(P ¼ .007), functional etiology (P ¼ .010; odds ratio [OR]
¼ 3.3), chronic obstructive pulmonary disease (P ¼ .013;
OR ¼ 3.4), peripheral vascular disease (P ¼ .014; OR ¼
4.2), and atherosclerotic aorta (P ¼ .03; OR ¼ 2.8) (Table
1). Initial analysis of risk factors for neurologic events re-
vealed associations with advanced age (P¼ .02), retrograde
perfusion (P ¼ .001; OR ¼ 3.8; 95% confidence interval
[CI] ¼ 1.7-8.1), and emergency procedure (P ¼ .01; OR
¼ 66.6; 95% CI ¼ 3.6-1000) (Table 1). Further analysis
was performed by identifying patients in whom retrograde
arterial perfusion was typically considered a ‘‘high risk’’:
those with peripheral vascular disease, cerebrovascular dis-
ease, dialysis, and atherosclerotic aortas. LogisticThe Journal of Thoracic and Carregression with bootstrapping revealed that the most and
only significant risk factor for a neurologic event was the
use of retrograde perfusion in high-risk patients with dis-
ease of the aorta (P ¼ .04; OR ¼ 8.5; 95% CI ¼ 1.1-72).
Analysis of the successive tertiles during this 12-year ex-
perience revealed a significant decrease in the use of retro-
grade arterial perfusion (89.6%, 10.4%, 0.0%; P<.001)
and endoaortic balloon occlusion (89.3%, 10.7%, 0.0%;
P< .001). The overall frequency of postoperative neuro-
logic events was 2.3% (30/1282) and decreased from
4.7% in the first tertile to 1.2% in the second and third ter-
tiles (P<.001).
DISCUSSION
A recent Society of Thoracic Surgeons Adult Cardiac
Surgery Database analysis4 associated ‘‘less invasive mitral
valve surgery’’ with similar mortality (as opposed to ster-
notomy) and with almost double the risk of stroke. The
strength of this association, however, was questionable ow-
ing to the imprecise definition of ‘‘less invasive surgery.’’ In
response, we5 recently critically reevaluated these findings
by reviewing a large minimally invasive valve experience
using precise data definitions. Our report ‘‘uncoupled’’ out-
comes by strictly and separately analyzing incision location
and arterial perfusion strategy; it demonstrated that adverse
neurologic outcomes were not associated with incision lo-
cation but were increased with the use of retrograde perfu-
sion. In particular, the use of retrograde arterial perfusion in
the setting of vascular disease demonstrated the greatest risk
for neurologic complication.
This current report focuses on a more homogeneous sub-
set of operations (first-time mitral valve repairs) and the
changes in perfusion strategies for these patients. First-
time mitral surgery typically involves a group of patients
with low risk of neurologic complication as evidenced by
the 1.2% incidence of postoperative stroke in our more re-
cent cohorts. This is in contrast to complex mitral surgery in
the setting of prior cardiac operations, where neurologic
complications can range from 3.8%6 to 7.5%.7 With the
great majority of our mitral patients being operated on by
a right minithoracotomy, we now rely primarily on direct
ascending aortic cannulation to provide antegrade arterial
perfusion and obviate concerns associated with retrograde
perfusion.
Our data set suggests that if in older patients a femoral
perfusion technique is chosen, preoperative evaluation of
the aorta and distal vasculature would be indicated to dem-
onstrate that a given patient would not be at increased neu-
rologic risk. This would include computed tomographic
angiography of the aorta with runoff and transesophageal
echocardiographic evaluation of the descending aorta.
Such a thoughtful screening approach has been used by
Murphy and associates8 for their patients having robotic
mitral surgery, with a reported stroke rate of 1.6%.diovascular Surgery c Volume 143, Number 4S S69
TABLE 1. Multivariable analysis of complications in 1282 patients
undergoing primary minimally invasive mitral valve repairs
Odds ratio P value
Risk factors for death
Increased age N/A .007
Functional mitral insufficiency 3.3 .010
Chronic obstructive pulmonary disease 3.4 .013
Peripheral vascular disease 4.2 .014
Atherosclerotic aorta 2.8 .03
Risk factors for neurologic events (simple logistic model)
Increased age N/A .02
Retrograde arterial perfusion 3.8 .001
Emergency procedure 66.6 .01
Risk factors for neurologic events bootstrapped, interaction model
Retrograde perfusion in high risk aorta 8.5 .04
Increased age N/A .11
Emergency procedure 1.6 .09
N/A, Not available.
Technical Considerations Grossi et alCONCLUSIONS
A right anterior minithoracotomy with central aortic can-
nulation has become our ‘‘go-to’’ strategy for the majority
of patients undergoing isolated mitral valve repair. This
strategy is associated with a low risk of neurologic compli-
cations and excellent clinical outcomes. Retrograde arterial
perfusion in older patients with peripheral vascular disease
or disease of the aorta is associated with an increased risk of
stroke; however, this strategy is not associated with anS70 The Journal of Thoracic and Cardiovascular Surgincreased risk of stroke in other patient cohorts. We there-
fore reserve retrograde perfusion for select patients without
significant peripheral vascular or aortic atherosclerotic
disease.
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